Find a Supplier
ADD YOUR COMPANY
HAPILA extends role in ATHANA nanoparticle antifungal alliance to regulatory support
Contact Us Subscribe to Newsletter
Contact Supplier

Contact Supplier

To get in touch with HAPILA GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    HAPILA extends role in ATHANA nanoparticle antifungal alliance to regulatory support

    HAPILA GmbH News Releases

    Find the latest News from HAPILA GmbH

    Page 1 of 3
    HAPILA extends role in ATHANA nanoparticle antifungal alliance to regulatory support
    HAPILA extends role in ATHANA nanoparticle antifungal alliance to regulatory support

    Wednesday 8th January 2025

    By  HAPILA GmbH Learn More >
    HAPILA teams with Transo-Pharm to present end-to-end API expertise at CPHI Milan
    HAPILA teams with Transo-Pharm to present end-to-end API expertise at CPHI Milan

    Tuesday 17th September 2024

    By  HAPILA GmbH Learn More >
    Successful debut for HAPILA at CPHI China 2024
    Successful debut for HAPILA at CPHI China 2024

    Thursday 18th July 2024

    By  HAPILA GmbH Learn More >
    HAPILA brings advanced API and synthesis capabilities to Chemspec Europe 2024
    HAPILA brings advanced API and synthesis capabilities to Chemspec Europe 2024

    Tuesday 11th June 2024

    By  HAPILA GmbH Learn More >
    HAPILA overcomes supply bottlenecks to synthesize anti-TB API agent BTZ-043 for clinical trials
    HAPILA overcomes supply bottlenecks to synthesize anti-TB API agent BTZ-043 for clinical trials

    Thursday 6th June 2024

    By  HAPILA GmbH Learn More >
    HAPILA bringing end-to-end API supply chain solutions to CPHI Barcelona
    HAPILA bringing end-to-end API supply chain solutions to CPHI Barcelona

    Friday 20th October 2023

    By  HAPILA GmbH Learn More >
    HAPILA and ATHANA alliance receive funding for nanoparticle antifungal program
    HAPILA and ATHANA alliance receive funding for nanoparticle antifungal program

    Wednesday 13th September 2023

    By  HAPILA GmbH Learn More >
    HAPILA’s co-developed anti-TB agent BTZ-043 named ‘Drug of the Year’
    HAPILA’s co-developed anti-TB agent BTZ-043 named ‘Drug of the Year’

    Friday 8th September 2023

    By  HAPILA GmbH Learn More >
    HAPILA shows advanced API development capabilities at Chemspec Europe 2023
    HAPILA shows advanced API development capabilities at Chemspec Europe 2023

    Thursday 11th May 2023

    By  HAPILA GmbH Learn More >
    HAPILA finds high demand for its enhanced API development and supply capabilities at CPHI Frankfurt
    HAPILA finds high demand for its enhanced API development and supply capabilities at CPHI Frankfurt

    Friday 9th December 2022

    By  HAPILA GmbH Learn More >
    HAPILA commences cGMP pilot scale manufacture of anti-TB API BTZ-043
    HAPILA commences cGMP pilot scale manufacture of anti-TB API BTZ-043

    Wednesday 16th November 2022

    By  HAPILA GmbH Learn More >
    HAPILA brings API manufacturing solutions to Chemspec Europe 2022
    HAPILA brings API manufacturing solutions to Chemspec Europe 2022

    Friday 8th July 2022

    By  HAPILA GmbH Learn More >
    Page 1 of 3
    Full Supplier Profile